Short talks Pharmacology 10
Pharmacoepidemiology and drug safety

Programme

• 09:00 – 09:15 10 Min. 5 Min.

  • Oral presentation
  • 46

  Analysis of sex-specific differences in spontaneously submitted and systematically collected reports of serious adverse drug reactions

  • Diana Dubrall (Bonn / DE)

   Pharmacoepidemiology and drug safety , Pharmacogenomics and personalized medicine
• 09:15 – 09:30 10 Min. 5 Min.

  • Oral presentation
  • 47

  Comparison of provided information and quality of documentation in spontaneous reports of adverse drug reactions from consumers, physicians and pharmacists

  • Patrick Christ (Bonn / DE)

   Pharmacoepidemiology and drug safety
• 09:30 – 09:45 10 Min. 5 Min.

  • Oral presentation
  • 48

  Documentation of drug-related problems with ICD-11 – development and application of a decision algorithm for clinicians and clinical coders

  • Lea Jung-Poppe (Erlangen / DE)

   Pharmacoepidemiology and drug safety , Pharmacological education
• 09:45 – 10:00 10 Min. 5 Min.

  • Oral presentation
  • 49

  Drug consumption in German cities and municipalities during the COVID-19 lockdown: a wastewater analysis

  • Bertold Renner (Dresden / DE)

   CNS / endocrine pharmacology, Pharmacoepidemiology and drug safety
• 10:00 – 10:15 10 Min. 5 Min.

  • Oral presentation
  • 50

  Prescribing practices of antipsychotics for the treatment of schizophrenia in older age

  • Oliver Zolk (Rüdersdorf / DE)

   CNS / endocrine pharmacology, Pharmacoepidemiology and drug safety
• 10:15 – 10:30 10 Min. 5 Min.

  • Oral presentation
  • 51

  Pre-operative medication assessment and optimization to improve clinical outcomes of women with ovarian cancer: subproject of the prospective KORE-INNOVATION trial.

  • Fabian Meinert (Berlin / DE)

   Pharmacoepidemiology and drug safety